Dr. Grazia M. Aleppo, MD

Dr. Aleppo practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Aleppo's NPI, 1689603268, was assigned on July 3, 2006. Dr. Aleppo graduated from Univ Catania- Fac Med in 1990. Dr. Aleppo holds Illinois license 036099550.

Dr. Aleppo's primary practice is Northwestern Medical Group, at 675 N St Clair St, Chicago, IL 60611 in Cook County. The practice phone is (312) 695-0646.

Dr. Aleppo's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Aleppo is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Aleppo to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aleppo practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Aleppo's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Aleppo is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Aleppo is licensed in Illinois.

Dmand AI lists chronic diabetes, diabetic emergency, high cholesterol, osteoporosis and underactive thyroid among the conditions Dr. Aleppo treats.

CMS data shows 830 Medicare services from Dr. Aleppo across 8 procedure codes in 2024, for 248 Medicare patients. Medicare paid $46,644 for them.

CMS counts 248 Medicare patients who saw Dr. Aleppo in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have diabetes, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aleppo's median patient age at 55, with 52% women.

In 2024, Dr. Aleppo wrote 2,361 Medicare Part D claims for 285 patients. 31% of them were for generic drugs. CMS names the drug for 2,100 of them, across 45 drugs with 11 or more claims each, at $1,349,841 in total drug cost. In 2023, CMS named 2,232 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Aleppo for performance year 2024, reported through an alternative payment model (APM). Dr. Aleppo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aleppo as offering telehealth.

Dmand AI links 92 papers to Dr. Aleppo, published from 2013 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Blood Glucose, Diabetes Mellitus, Type 1 and Blood Glucose Self-Monitoring. Dr. Aleppo has published most often in Diabetes Care. Dr. Aleppo's most frequent co-authors are Irl B. Hirsch, Carol Joan Levy, MD and Richard M. Bergenstal, MD.

Dmand AI links Dr. Aleppo to 4 clinical trials. Conditions studied include Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 and Rejection, Psychology. Tandem Diabetes Care, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Aleppo that name 3 trials.

CMS Open Payments shows 260 general payments to Dr. Aleppo from 16 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 36% of the total. Dexcom, Inc. paid the most, $124,829. It also lists 9 research payments totaling $4,791 from 2020 to 2025, naming 3 clinical trials.

Dmand AI lists 5 awards for Dr. Aleppo, most recently Fellow (FACP) in 2012.

Dr. Aleppo graduated from Univ Catania- Fac Med in 1990. Dr. Aleppo is a member of AACE, ACP, ADA and ENDO.

Dr. Aleppo is in network with 15 carriers, including HCSC, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.